Healthcare - Biotechnology - NASDAQ - US
$ 3.19
0.315 %
$ 56.7 M
Market Cap
-0.44
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
100.76%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
BioVie Inc.
BIVI has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart BIVI
EBIT FORECAST
EBIT Forecast Chart BIVI
NET INCOME FORECAST
Net Income Chart BIVI